480 research outputs found
Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation
Retinal pigment epithelium (RPE) is a major part of blood-retinal barrier that affects drug elimination from the vitreous to the blood and drug distribution from blood circulation into the eye. Even though drug clearance from the vitreous has been well studied, the role of RPE in the process has not been quantified. The aim of this work was to study the role of RPE clearance (CLRpE) as part of drug elimination from the vitreous and ocular drug distribution from the systemic blood circulation. We determined the bidirectional permeability of eight small molecular weight drugs and bevacizumab antibody across isolated bovine RPE-choroid. Permeability of small molecules was 10(-6) -10(-5)cm/s showing 13-15 fold range of outward and inward permeation, while permeability of bevacizumab was lower by 2-3 orders of magnitude. Most small molecular weight drugs showed comparable outward (vitreous-to-choroid) and inward (choroid-to-vitreous) permeability across the RPEchoroid, except ciprofloxacin and ketorolac that had an over 6 and 14-fold higher outward than inward permeability, respectively, possibly indicating active transport, Six of seven tested small molecular weight drugs had outward CLRPE values that were comparable with their intravitreal clearance (CLIvr) values (0.84-2.6 fold difference). On the contrary, bevacizumab had an outward CLRPE that was only 3.5% of the CLIvt, proving that its main route of elimination (after intravitreal injection) is not RPE permeation. Experimental values were used in pharmacokinetic simulations to assess the role of the RPE in drug transfer from the systemic blood circulation to the vitreous (CLBv). We conclude that for small molecular weight drugs the RPE is an important route in drug transfer between the vitreal cavity and blood, whereas it effectively hinders the movement of bevacizumab from the vitreous to the systemic circulation.Peer reviewe
An empirical investigation of dance addiction
Although recreational dancing is associated with increased physical and psychological well-being, little is known about the harmful effects of excessive dancing. The aim of the present study was to explore the psychopathological factors associated with dance addiction. The sample comprised 447 salsa and ballroom dancers (68% female, mean age: 32.8 years) who danced recreationally at least once a week. The Exercise Addiction Inventory (Terry, Szabo, & Griffiths, 2004) was adapted for dance (Dance Addiction Inventory, DAI). Motivation, general mental health (BSI-GSI, and Mental Health Continuum), borderline personality disorder, eating disorder symptoms, and dance motives were also assessed. Five latent classes were explored based on addiction symptoms with 11% of participants belonging to the most problematic class. DAI was positively associated with psychiatric distress, borderline personality and eating disorder symptoms. Hierarchical linear regression model indicated that Intensity (ß=0.22), borderline (ß=0.08), eating disorder (ß=0.11) symptoms, as well as Escapism (ß=0.47) and Mood Enhancement (ß=0.15) (as motivational factors) together explained 42% of DAI scores. Dance addiction as assessed with the Dance Addiction Inventory is associated with indicators of mild psychopathology and therefore warrants further research
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Background & Aims: Non-invasive tests (NITs) offer a practical solution for advanced fibrosis identification in non-alcoholic fatty liver disease (NAFLD). Despite increasing implementation, their use is not standardised, which can lead to inconsistent interpretation and risk stratification. We aimed to assess the types of NITs and the corresponding cut-offs used in a range of healthcare settings. / Methods: A survey was distributed to a convenience sample of liver health experts who participated in a global NAFLD consensus statement. Respondents provided information on the NITs used in their clinic with the corresponding cut-offs and those used in established care pathways in their areas. / Results: There were 35 respondents from 24 countries, 89% of whom practised in tertiary level settings. A total of 14 different NITs were used, and each respondent reported using at least one (median = 3). Of the respondents, 80% reported using FIB-4 and liver stiffness by vibration-controlled transient elastography (Fibroscan®), followed by the NAFLD fibrosis score (49%). For FIB-4, 71% of respondents used a low cut-off of 7.5 to >20 kPa, respectively). / Conclusions: The cut-offs used for the same NITs for NAFLD risk stratification vary between clinicians. As cut-offs impact test performance, these findings underscore the heterogeneity in risk-assessment and support the importance of establishing consistent guidelines on the standardised use of NITs in NAFLD management. / Lay summary: Owing to the high prevalence of non-alcoholic fatty liver disease (NAFLD) in the general population it is important to identify those who have more advanced stages of liver fibrosis, so that they can be properly treated. Non-invasive tests (NITs) provide a practical way to assess fibrosis risk in patients. However, we found that the cut-offs used for the same NITs vary between clinicians. As cut-offs impact test performance, these findings highlight the importance of establishing consistent guidelines on the standardised use of NITs to optimise clinical management of NAFLD
Field testing for toxic algae with a microarray: initial results from the MIDTAL project
One of the key tasks in the project MIDTAL (MIcroarrays for the Detection of Toxic ALgae) is to demonstrate the applicability of microarrays to monitor harmful algae across a broad range of ecological niches and toxic species responsible for harmful algal events. Water samples are collected from a series of sites used in national phytoplankton and biotoxin monitoring programmes across Europe. The samples are filtered; the rRNA is extracted, labelled with a fluorescent dye and applied to a microarray chip. The signal intensity from >120 probes previously spotted on the chip is measured and analysed. Preliminary results comparing microarray signal intensities with actual field counts are presented
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Background & Aims: Non-invasive tests (NITs) offer a practical solution for advanced fibrosis identification in non-alcoholic
fatty liver disease (NAFLD). Despite increasing implementation, their use is not standardised, which can lead to inconsistent
interpretation and risk stratification. We aimed to assess the types of NITs and the corresponding cut-offs used in a range of
healthcare settings.
Methods: A survey was distributed to a convenience sample of liver health experts who participated in a global NAFLD
consensus statement. Respondents provided information on the NITs used in their clinic with the corresponding cut-offs and
those used in established care pathways in their areas.
Results: There were 35 respondents from 24 countries, 89% of whom practised in tertiary level settings. A total of 14 different
NITs were used, and each respondent reported using at least one (median = 3). Of the respondents, 80% reported using FIB-4
and liver stiffness by vibration-controlled transient elastography (Fibroscan®), followed by the NAFLD fibrosis score (49%). For
FIB-4, 71% of respondents used a low cut-off of <1.3 (range <1.0 to <1.45) and 21% reported using age-specific cut-offs. For
Fibroscan®, 21% of respondents used a single liver stiffness cut-off: 8 kPa in 50%, while the rest used 7.2 kPa, 7.8 kPa and
8.7 kPa. Among the 63% of respondents who used lower and upper liver stiffness cut-offs, there were variations in both values
(7.5 to >20 kPa, respectively). Conclusions: The cut-offs used for the same NITs for NAFLD risk stratification vary between clinicians. As cut-offs impact test
performance, these findings underscore the heterogeneity in risk-assessment and support the importance of establishing
consistent guidelines on the standardised use of NITs in NAFLD management.
Lay summary: Owing to the high prevalence of non-alcoholic fatty liver disease (NAFLD) in the general population it is
important to identify those who have more advanced stages of liver fibrosis, so that they can be properly treated. Noninvasive tests (NITs) provide a practical way to assess fibrosis risk in patients. However, we found that the cut-offs used
for the same NITs vary between clinicians. As cut-offs impact test performance, these findings highlight the importance of
establishing consistent guidelines on the standardised use of NITs to optimise clinical management of NAFLD
Evidence of extreme domain wall speeds under ultrafast optical excitation
Time-resolved ultrafast EUV magnetic scattering was used to test a recent
prediction of >10 km/s domain wall speeds by optically exciting a magnetic
sample with a nanoscale labyrinthine domain pattern. Ultrafast distortion of
the diffraction pattern was observed at markedly different timescales compared
to the magnetization quenching. The diffraction pattern distortion shows a
threshold-dependence with laser fluence, not seen for magnetization quenching,
consistent with a picture of domain wall motion with pinning sites. Supported
by simulations, we show that a speed of 66 km/s for highly curved
domain walls can explain the experimental data. While our data agree with the
prediction of extreme, non-equilibrium wall speeds locally, it differs from the
details of the theory, suggesting that additional mechanisms are required to
fully understand these effects.Comment: 5 pages, 4 figures; Supplemental Material: 8 pages, 9 figure
- …